28 de octubre de 2021
LA JOLLA—Profesor del Salk Tatyana Sharpee ha ganado el Premio DeLano 2022 en Biociencias Computacionales de la Sociedad Estadounidense de Bioquímica y Biología Molecular (ASBMB). El premio se otorga a un científico con un desarrollo o aplicación innovadora de una tecnología informática que pueda mejorar la investigación en ciencias de la vida a nivel molecular.
“Tanya’s cutting-edge computational approach to neurobiology research shows exciting promise for new insights into the aging process and disease,” says Salk President Rusty Gage. “We are thrilled the Society has recognized her for her groundbreaking work.”
Sharpee is the second woman to receive the Delano Award for Computational Biosciences since its inception. The award includes a plaque, a $3,000 prize and paid travel for Sharpee to present a lecture at the annual ASBMB meeting in Philadelphia, in April 2022.
Sharpee, who holds the Edwin K. Hunter Chair, studies how the brain and other biological systems work and uses information theory to quantify the activity of neurons. In one area of research, she seeks to determine how features are organized within parts of the brain that are responsible for conveying our senses, including vision, hearing and the sense of smell. Revealing the workings of these core senses could help lead to new treatments and brain-machine interfaces for patients with disruptions to these systems, which can happen as a result of stroke, dementia or with schizophrenia.
Profesor Salk Tony Hunter, who is an ASBMB member, nominated Sharpee for the award.
The DeLano Award for Computational Biosciences was established by family, friends and colleagues to honor the legacy of Warren L. DeLano, who passed away suddenly in 2009 and was best known for his computer system PyMOL, an open-source program for visualization of complex macromolecular systems.
Oficina de Comunicaciones
Tel.: (858) 453-4100
press@salk.edu
El Instituto Salk es un centro de investigación independiente y sin fines de lucro fundado en 1960 por Jonas Salk, creador de la primera vacuna segura y eficaz contra la poliomielitis. La misión del Instituto es impulsar una investigación fundamental, colaborativa y audaz que aborde los retos más acuciantes de la sociedad, entre ellos el cáncer, la enfermedad de Alzheimer y la vulnerabilidad agrícola. Esta ciencia fundamental sustenta todos los esfuerzos traslacionales, generando conocimientos que permiten el desarrollo de nuevos medicamentos e innovaciones en todo el mundo.
